A phase-II study of adoptive immunotherapy with continuous infusion of interleukin-2 in children with advanced neuroblastoma. A report on 11 cases
- 30 June 1989
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 16, 129-142
- https://doi.org/10.1016/0305-7372(89)90033-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Interleukin-2 with and without LAK cells in metastatic renal cell carcinoma: the Lyon first-year experience in 20 patientsCancer Treatment Reviews, 1989
- Interleukin 2 enhances cytotoxic cell function in vitro after T-cell depleted marrow transplantationBritish Journal of Haematology, 1987
- ABSENCE OF CELL SURFACE LFA-1 AS A MECHANISM OF ESCAPE FROM IMMUNOSURVEILLANCEThe Lancet, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Defective interleukin 2 receptor expression is associated with the T cell disfunction subsequent to bone marrow transplantationEuropean Journal of Immunology, 1987
- Definition of Response And Remission in Children Over one Year of Age with Advanced Neuroblastoma: Proposition for a Scoring SystemPediatric Hematology and Oncology, 1987
- Optimal methods for generating expanded lymphokine activated killer cells capable of reducing established murine tumors in vivoJournal of Immunological Methods, 1986
- Natural killer cell activity following T-cell depleted allogeneic bone marrow transplantationBritish Journal of Haematology, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Recombinant interferon-γ can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigensEuropean Journal of Immunology, 1985